Evidence map›Paper›PMID 37285394›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Individual costs and societal benefits of interventions during the COVID-19 pandemic.

Arne Traulsen, Simon A Levin, Chadi M Saad-Roy

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Social dilemma of nonpharmaceutical interventions: Determinants of dynamic compliance and behavioral shifts.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. The evolution of post-infection mortality.Proceedings. Biological sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dynamics in a behavioral-epidemiological model for individual adherence to a nonpharmaceutical intervention.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Individual costs and societal benefits of interventions during the COVID-19 pandemic.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arne TraulsenMax Planck Institute for Evolutionary Biology, Department of Theoretical Biology, 24306 Plön, Germany.ORCID 0000-0002-0669-5267
Simon A LevinDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.ORCID 0000-0002-8216-5639
Chadi M Saad-RoyLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544.ORCID 0000-0002-2217-3071

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individual and societal reactions to an ongoing pandemic can lead to social dilemmas: In some cases, each individual is tempted to not follow an intervention, but for the whole society, it would be best if they did. Now that in most countries, the extent of regulations to reduce SARS-CoV-2 transmission is very small, interventions are driven by individual decision-making. Assuming that individuals act in their best own interest, we propose a framework in which this situation can be quantified, depending on the protection the intervention provides to a user and to others, the risk of getting infected, and the costs of the intervention. We discuss when a tension between individual and societal benefits arises and which parameter comparisons are important to distinguish between different regimes of intervention use.

Indexed as

COVID-19Cooperative BehaviorGame TheoryHumansPandemicsSARS-CoV-2evolutionary game theoryprisoner’s dilemmasocial conflict

Identifiers

PMID37285394
PMCPMC10268224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.